Save the Date for ACT-AD’s Tenth Annual FDA/AD Allies Meeting, November 16
Mark your calendars! ACT-AD’s Tenth Annual FDA/AD Allies Meeting is set for Thursday, November 16, 2017, at the Bethesda North Marriott Hotel and Conference Center (5701 Marinelli Road, North Bethesda, Maryland 20852). The meeting will begin at 9:30 a.m. and end by 4:00 p.m. To register for the event, go here.
ACT-AD Hosts Webinar on Alzheimer’s Disease Research Framework, July 25
On July 25, ACT-AD will host a webinar on the updated National Institute on Aging-Alzheimer’s Association Research Framework for Alzheimer’s Disease. The one-hour program will feature expert perspectives on the topic and will conclude with a moderated Q & A to allow participants an opportunity to ask questions. Clifford R. Jack Jr, MD, of the Mayo Clinic, and Paul Stephen Aisen, MD, of USC, will speak on the webinar. A registration page is available here.
FDA Seeks Feedback on Office of Patient Affairs
As part of their efforts to better capture patients’ perspectives, the U.S. Food and Drug Administration (FDA) is considering establishing an “Office of Patient Affairs.” This office would be tasked with supporting and coordinating patient engagement across the Agency. The FDA opened a public docket to receive feedback from stakeholders through June 12. To read submissions received by the FDA, including comments from ACT-AD’s Executive Director, click here.
Researchers Say Alzheimer’s Disease Begins Before Symptoms Start
A research team at the Keck School of Medicine of the University of Southern California found that Alzheimer’s disease impacts the brain before the disease’s effects take place. The study noted that older adults with normal cognitive function, but high amounts of amyloid plaques in their brains, experience a “faster mental decline.” The researchers say their discovery could lead to more options to treat Alzheimer’s disease in its earliest stages. To learn more about the study, go here.
Chronic Pain May Be Associated with Increased Risk of Dementia
Researchers at the University of California San Francisco say older adults with persistent pain exhibit faster memory declines as they age and are more likely to have dementia. The study included 10,000 participants ages 60 and above over 12 years, finding that participants with moderate to severe pain declined 9.2 percent faster in memory function than those without pain. These findings could open up new avenues of treatment for cognitive impairment, according to the researchers. “Up to one in three older people suffer from chronic pain, so understanding the relationship between pain and cognitive decline is an important first step toward finding ways to help this population,” said study author Elizabeth Whitlock, MD, MSc. To learn more about the study, go here.
Certain Diets Can Increase Alzheimer’s Pathology in Animal Models
A recent study found that obese mice with a specific type of gene associated with Alzheimer’s disease in humans displayed increased Alzheimer’s pathology. In the study, the researchers found that obese mice carrying the APOE4 gene had increased beta-amyloid deposits as a result of consuming a Western-like diet, which is high in saturated fat and sugar. The findings, published in eNeuro, notes that people with the gene APOE4 face an increased risk of AD, but not all carriers develop the gene. To read more about this discovery, go here.
NIH Hosts Summit on the Science of Caregiving
The National Institute of Nursing Research (NINR) will host a summit titled “The Science of Caregiving: Bringing Voices Together,” August 7-8, 2017 at the Natcher Building on the NIH Campus. The goals of the summit include: providing perspectives across the spectrum of caregiving, the importance of caregiving across the lifespan, and future directions for research to improve the health of patients and caregivers. The keynote speaker is Judy Woodruff of PBS NewsHour, and the Directors of Ceremonies are Gail Hunt of the National Alliance for Caregiving and Dr. Laura Gitlin of the Center for Innovative Care in Aging at the Johns Hopkins University. This event is open to the public. To register, go here.
ADDF’s Conference on Alzheimer’s Drug Discovery, September 11-12, 2017
The Alzheimer’s Drug Discovery Foundation will hold its 18th Annual International Conference on Alzheimer’s Drug Discovery in Jersey City, New Jersey. The two-day event will gather top researchers, who are developing innovative treatments for Alzheimer’s disease and related dementias. Scholarships are available for graduate students and postdoctoral fellows to attend the conference at no cost. More information about the scholarship can be found here. General details about the conference are available here.
AFA Hosts National Educating America Tour, September 14, 2017
The Alzheimer’s Foundation of America will host their “National Educating America Tour,” as part of their Concepts in Care Educational Conferences in Washington, D.C. (1526 New Hampshire Ave., NW). The free event will allow attendees to hear from experts on a variety of topics such as access to health care, long-term care, perceptions of aging, and research. Registration details can be found here.